52 Week Range
As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Performance Health To Sell Its Biofreeze And Therapearl Brands To Reckitt Benckiser Group Plc
Reckitt Benckiser Announces Sale Of Scholl To Yellow Wood Partners
Reckitt Benckiser FY Adj Diluted EPS 327p
Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene, post-natal and home products. The Company's segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN). Health, Hygiene, Home and Portfolio Brands categories are split across the geographical segments of ENA and DVM. Its range of hygiene products includes disinfectant cleaners, automatic dishwashing detergents, pest control, depilatory products and acne treatments. The Company's portfolio of brands includes Durex, Mucinex, Scholl, Strepsils, Cillit Bang, Clearasil, Dettol, Harpic, Lysol, Mortein, Veet, Air Wick, Calgon, Queen V, Vanish and Woolite.
Personal & Household Prods.
103-105 Bath Road
Christopher Alan Sinclair
Non-Executive Chairman of the Board
Chief Executive Officer, Director
Chief Financial Officer, Executive Director
President - Health, Global Chief Customer Officer
President - Nutrition, President China and E-RB
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
British consumer goods group Reckitt Benckiser expects to maintain strong sales this year, it said on Wednesday as it posted record pandemic-driven sales in 2020 and announced the disposal of its Scholl footcare business.
Concise insights on global finance in the Covid-19 era.
Indivior said on Monday former parent Reckitt Benckiser would withdraw a $1.4 billion claim against the company and it would pay the Dettol-maker $50 million to end a legal battle related to a U.S. probe into opioid addiction.
Indivior said on Monday its former parent Reckitt Benckiser had withdrawn a $1.4 billion claim against the drugmaker as part of a 2019 settlement with U.S. authorities to end a probe into the companies' opioid addiction treatment.
British drugmaker Indivior Plc said on Monday it would "vigorously defend" against a 1.07 billion pound ($1.43 billion) legal claim from consumer good maker Reckitt Benckiser Group relating to their demerger agreement.
Consumer good maker Reckitt Benckiser earlier this month submitted a 1.07 billion pound ($1.43 billion) claim to the Commercial Court in London against Indivior relating to their demerger agreement, the drug developer said on Friday.
Reckitt Benckiser has submitted a 1.07 billion pound claim to the Commercial Court in London against UK-listed drug developer Indivior earlier this month, relating to their demerger agreement, Indivior said on Friday.
Reckitt Benckiser <RB.L> reported a much bigger-than-expected rise in third-quarter sales on Tuesday and raised its full-year outlook, as the coronavirus pandemic lifts demand for cleaning products such as Dettol and Lysol.
London's FTSE 100 fell on Tuesday on concerns over tougher coronavirus lockdowns in parts of England and Brexit-related uncertainty, although losses were limited due to upbeat quarterly results from Reckitt Benckiser.
Reckitt Benckiser on Tuesday reported a bigger-than-expected rise in third-quarter sales that were boosted as the coronavirus pandemic spurred demand for cleaning products.
Consumer goods group Reckitt Benckiser Group <RB.L> is preparing to sell some of its non-core personal care brands, including Veet hair removal cream and Clearasil acne cream, four sources familiar with the matter said on Monday.
Delta Air Lines <DAL.N> said on Monday it is teaming up with Reckitt Benckiser Group Plc <RB.L>, the makers of Lysol, to research and develop new disinfecting solutions for high-traffic areas in airports and onboard, with a first focus on airplane lavatories.
A month-old Brazilian company's machines that use bacteria to break down organic waste has found users among domestic upscale supermarket Natural da Terra, units of Reckitt Benckiser <RB.L> and Siemens AG <SIEGn.DE>, and logistics firm Luft, its chief executive said on Thursday...
UK-based Reckitt Benckiser Group Plc <RB.L> said on Tuesday that the U.S. Environmental Protection Agency (EPA) has approved use of its Lysol Disinfectant Spray against COVID-19.
Reckitt Benckiser <RB.L> achieved record sales growth in the first quarter and predicted a stronger than expected performance in 2020 as customers stocked up on Lysol disinfectants, Mucinex cough syrup and Dettol soap ahead of the coronavirus lockdowns.
UK stock markets rose on Thursday as investors cheered signs of progress in developing a treatment for the novel coronavirus, while Reckitt Benckiser surged after reporting strong demand for its products ahead of the lockdown.
* RECKITT - QTRLY REVENUE 3,544 MILLION STG VERSUS 3,157 MILLION STG AS REPORTED A YEAR EARLIER
* RECKITT BENCKISER- CO'S DISINFECTANT PRODUCTS SHOULD NOT BE ADMINISTERED INTO HUMAN BODY THROUGH INJECTION, INGESTION, ANY OTHER ROUTE Source text: https://bit.ly/3cHBvkY Further company coverage:
* RECKITT BENCKISER - ANNOUNCING LAUNCH OF THE RB FIGHT FOR ACCESS FUND TO IMPROVE ACCESS TO HEALTH, HYGIENE AND NUTRITION FOR ALL
* RECKITT -AWARE OF SOCIAL MEDIA IN FRANCE CONCERNS ON USE OF STEROIDS & NON-STEROIDAL ANTI-INFLAMMATORY PRODUCTS FOR ALLEVIATION OF COVID-19 SYMPTOMS
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.